Abstract
Purpose
The prostate-specific antigen density (PSAD) helps distinguish between benign prostatic hyperplasia (BPH) and prostate cancer. Accurate prostate volume (PV) assessment is necessary for PSAD calculation and both BPH diagnosis and treatment response monitoring; therefore, accurate PV measurement is increasingly becoming an essential step in the urology.
Methods
Magnetic resonance imaging was used for PV estimation. A new technique based on single-class support-vector machines (S SVM) for accurate PV estimation was realized. Three estimation methods were compared; method 1: planimetry (reference), method 2: S SVM based, and method 3: prolate ellipsoid.
Results
Method 1 and method 2 depict a strong correlation (Spearman’s rank correlation coefficient ρ = 0.965, p > 0.001). The interrater reliability for method 1 and method 2 readings as expressed by the intraclass correlation coefficient (ICC) was 0.975 (p > 0.001). Comparison between method 3 and the two other methods shows ρ = 0.873 (p > 0.001), and ρ = 0.795 (p > 0.001), respectively. ICC was 0.54 and 0.505, respectively. The mean difference between method 1 and method 2 was −0.05 ml. The limits of agreement with the 95 % confidence interval were −3.8 to 3.7 ml. Comparing method 3 and the two other methods shows a worse agreement with mean difference of 8.6 ml (95 % confidence interval of 1.0–16.2 ml) and 8.6 ml (95 % confidence interval of −0.7 to 18.0 ml), respectively.
Conclusions
The prostate volumes obtained by our technique agreed excellently with the planimetry (reference) method. This new technique would be clinically useful for urologists in prostate volumetric analysis.
Similar content being viewed by others
Abbreviations
- BPH:
-
Benign prostatic hyperplasia
- TRUS:
-
Transrectal ultrasound
- PV:
-
Whole prostate volume
- PSA:
-
Prostate-specific antigen
- MRI:
-
Magnetic resonance imaging
- PSAD:
-
Prostate-specific antigen density
References
Zoltan E, Lee R, Staskin DR et al (2008) Combination therapy for benign prostatic hyperplasia: does size matter? Curr Bladder Dysfunct Rep 3(2):102–108
Stamey TA, Yang N, Hay AR et al (1987) Prostate specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 317(15):909–916
Vesely S, Knutson T, Damber JE et al (2003) Relationship between age, prostate volume, prostate-specific antigen, symptom score and uroflowmetry in men with lower urinary tract symptoms. Scand J Urol Nephrol 37(4):322–328
Kim JM, Song PH, Kim HT et al (2011) Effect of obesity on prostate-specific antigen, prostate volume, and international prostate symptom score in patients with benign prostatic hyperplasia. Korean J Urol 52(6):401–405
Milonas D, Trumbeckas D, Juska P (2003) The importance of prostatic measuring by transseptal ultrasound in surgical management of patients with clinically benign prostatic hyperplasia. Medicina (Kaunas) 39(9):860–866
Völzke H, Alte D, Schmidt CO et al (2011) Cohort profile: the study of health in Pomerania. Int J Epidemiol 40(2):294–307
Hegenscheid K, Kühn JP, Völzke H et al (2009) Whole-body magnetic resonance imaging of healthy volunteers: pilot study results from the population-based SHIP study. Rofo 181(8):748–759
Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9(7):671–675
Cortes C, Vapnik V (1995) Support-vector networks. Mach Learn 20(3):273–297
Schölkopf B, Smola AJ (2001) Learning with Kernels: support vector machines, regularization, optimization, and beyond. MIT Press, Massachusetts (USA)
Habes M, Schiller T, Rosenberg C et al (2013) Automated prostate segmentation in whole-body MRI scans for epidemiological studies. Phys Med Biol 58:5899–5916
Schölkopf B, Platt JC, Shawe-Taylor J et al (2001) Estimating the support of a high-dimensional distribution. Neural Comput 13(7):1443–1471
Bland MJ, Altman D (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 327(8476):307–310
Shrout PE, Fleiss JL (1979) Estimating the support of a high-dimensional distribution. Psychol Bull 86(2):420–428
Portney LG, Watkins MP (1993) Foundations of Clinical Research: applications to Practice Pearson/Prentice Hal, USA
Benson M, Whang I, Pantuck A et al (1992) Prostate septic antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol 147(3 Pt 2):815
Stephan C, Stroebel G, Heinau M et al (2005) The ratio of prostate-septic antigen (PSA) to prostate volume (PSA density) as a parameter to improve the detection of prostate carcinoma in PSA values in the range of <4 ng/ml. Cancer 104(5):993
Roehrborn CG, Boyle P, Gould AL, Waldstreicher J (1999) Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia. Urology 53(3):581–589
Morote J, Encabo G, Lopez M, de Torres IM (2000) Prediction of prostate volume based on total and free serum prostate–specific antigen: is it reliable? Eur Urol 38(1):91–95
Park T, Chae JY, Kim JW et al (2013) Prostate-specific antigen mass and free prostate-specific antigen mass for predicting the prostate volume of Korean men with biopsy-proven benign prostatic hyperplasia. Korean J Urol 54(9):609–614
Di Silverio F, Bosman C, Salvatori M et al (2005) Combination therapy with rofecoxib and finasteride in the treatment of men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH). Eur Urol 47(1):72–79
MacMahon PJ, Kennedy AM, Murphy DT et al (2009) Modified prostate volume algorithm improves transseptal US volume estimation in men presenting for prostate brachytherapy. Radiology 250(1):273–280
Kimura A, Kurooka Y, Kitamura T et al (1997) Biplane planimetry as a new method for prostatic volume calculation in transseptal. Int J Urol 4(2):152
Al-Rimawi M, Griffiths DJ, Boake RC et al (1994) Transseptal ultrasound versus magnetic resonance imaging in the estimation of prostatoc volume. BJU Int 74(5):596–600
Weiss BE, Wein AJ, Malkowicz SB et al (2012) Comparison of prostate volume measured by transrectal ultrasound and magnetic resonance imaging: is transrectal ultrasound suitable to determine which patients should undergo active surveillance? Urol Oncol 31(8):1436–1440
Turkbey B, Huang R, Vourganti S et al (2012) Age-related changes in prostate zonal volumes as measured by high-resolution magnetic resonance imaging (MRI): a cross-sectional study in over 500 patients. BJU Int 110(11):1642–1647
Acknowledgments
The present work has been supported by a joint grant from Siemens Healthcare, Erlangen, Germany and the Federal State of Mecklenburg-West Pomerania. The University of Greifswald is a member of the “Center of Knowledge Interchange” program of Siemens AG.
Conflict of interest
No conflict of interest to be declared.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Habes, M., Bahr, J., Schiller, T. et al. New technique for prostate volume assessment. World J Urol 32, 1559–1564 (2014). https://doi.org/10.1007/s00345-013-1220-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-013-1220-2